Drug Database
LO

loratadine (Clarityn RediTabs / Claritin Reditabs / loratadine, Zydis)

✓ Approved

Merck & Co. · HRH1 · 小分子

什么是 loratadine?

loratadine 是一种小分子,由Merck & Co.研发。该药已获批,用于治疗相关适应症,给药途径:Oral (PO)。

药物档案

商品名Clarityn RediTabs, Claritin Reditabs, loratadine, Zydis
公司Merck & Co.
药物类别小分子
分子靶点HRH1
给药途径Oral (PO)
状态Approved

作用机制

分子靶点

loratadine 作用于 1 个分子靶点:

HRH1histamine receptor H1 (HH1R, H1R)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

loratadine 针对 2 个适应症,涉及 2 个治疗领域。

治疗领域疾病/病症分期
Respiratory, thoracic and mediastinal disordersRhinitis allergic✓ Approved
Skin and subcutaneous tissue disordersUrticaria✓ Approved

相关研究文献

PubMedZhen ci yan jiu = Acupuncture research2026-11-18

[Mechanism of electroacupuncture at "Yingxiang-Hegu" (LI20-LI4) acupoints ameliorating allergic rhinitis in rats via modulating ILC2s through the IL-33/ST2 pathway].

Wu Han H, Lü Heng H, Zhang Hao H, Hu Zhixiang Z et al.

To investigate the regulatory effects of electroacupuncture at "Yingxiang-Hegu" (LI20-LI4) acupoints on the interleukin (IL)-33/growth stimulation expressed gene 2 (ST2) signaling pathway and type 2 innate lymphoid cells (ILC2s) in the nasal mucosa of allergic rhinitis (AR) rats, and to explore its therapeutic mechanism for AR. Forty-eight SD rats were randomly divided into a control group (n=12) and a modeling group (n=36). Ovalbumin (OVA)-induced AR model was established. Thirty-six successfully modeled rats were further randomized into a model group (n=12), a western medicine group (n=12), and an electroacupuncture group (n=12). The electroacupuncture group received acupuncture at the paired points "Yingxiang-Hegu"(LI20-LI4) with the ipsilateral LI20 and LI4 points connected to an electroacupuncture device. Stimulation parameters were set as follows:sparse-dense wave, frequency 2 Hz /100 Hz, current intensity 1-2 mA, needle retention for 20 min. The western medicine group received oral administration of loratadine(0.1 mg/100 g). Interventions were administered once daily for 14 consecutive days in all groups. Nasal allergy symptoms (nose scratching, sneezing and nasal discharge) were observed and scored before and after modeling, as well as after intervention. After intervention, histopathological change in the nasal mucosal tissue was examined via hematoxylin and eosin (HE) staining. ELISA was used to detect serum ovalbumin-specific immunoglobulin E (OVA-sIgE), IL-9, and IL-13 levels. Immunofluorescence double staining was used to assess ST2 and thymic cell antigen 1 (Thy1, also known as CD90) positive expression and ILC2s numbers in nasal mucosal tissue. Real-time quantitative PCR was used to detect the mRNA expression levels of GATA binding protein 3(GATA3), retinoic acid-related orphan receptor alpha (ROR-α), IL-33, ST2, IL-1 receptor accessory protein (IL-1RAcP), myeloid differentiation primary-response protein 88 (MyD88), i IL-1 receptor-associated kinase 4 (IRAK4), and nuclear factor κB p65 subunit (NF-κB p65) in nasal mucosal tissue. Western blot was used to measure the protein expression levels of IL-33, ST2 and MyD88 in nasal mucosal tissue. Following OVA sensitization, nasal allergy symptom scores in the model group were significantly elevated compared to the control group (all>5 points, P<0.001), indicating successful modeling. After intervention, the nasal allergy symptom scores in the model group remained persistently high compared to the control group (P<0.001). HE staining revealed disrupted nasal mucosal barrier and marked inflammatory response. Serum OVA-sIgE, IL-9 and IL-13 levels were significantly elevated (P<0.001);the number of ILC2s in the nasal mucosa significantly increased (P<0.001), with enhanced fluorescence intensities of ST2 and Thy1 (P<0.001). GATA3, ROR-α, IL-33, ST2, IL-1RAcP, MyD88, IRAK4 and NF-κB p65 mRNA expression levels were elevated (P<0.001, P<0.01), while IL-33, ST2 and MyD88 protein expression levels were increased (P<0.001). Compared with the model group, both the electroacupuncture and western medicine groups showed a reversal of all the above indicators (P<0.001, P<0.01, P<0.05);HE staining revealed reduced inflammatory infiltration in the nasal mucosa and improved tissue structural integrity. No statistically significant differences were observed between the electroacupuncture group and the western medicine group for any of the measured indicators. Electroacupuncture at "Yingxiang-Hegu"(LI20-LI4) acupoints ameliorates OVA-induced nasal mucosal inflammatory changes in AR rats. This effect may be mediated by inhibiting the IL-33/ST2 signaling pathway and down-regulating ILC2s expression, thereby improving allergic rhinitis in rats.

PMID 43051693
阅读全文 →
PubMedRevista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)2026-11-16

Dapsone-induced severe neutrophilic leukocytosis with left shift mimicking a myeloid neoplasm.

Criado Giulia Jardim GJ, Ferrari Rebecca Marini RM, Abdalla Beatrice Martinez Zugaib BMZ

Dapsone (4,4'-diaminodiphenylsulfone) is a sulfonamide derivative with well-established antimicrobial and anti-inflammatory properties, including inhibition of neutrophil chemotaxis, complement system suppression, and prostaglandin inhibition. Chronic spontaneous urticaria is defined by the recurrent appearance of transient, intensely pruritic wheals lasting less than 24 hours, with or without angioedema, persisting for more than six weeks without an identifiable external trigger. A 37-year-old female healthcare worker presented with intensely pruritic hives of two months' duration and intermittent angioedema of the lips. Laboratory tests were normal, except for a mildly elevated C-reactive protein level. Treatment with loratadine (40 mg/day) and montelukast was initiated but failed to control the disease. A subsequent skin biopsy confirmed the diagnosis of CSU. After verifying normal G6PD enzyme levels, dapsone was introduced at a dose of 25 mg/day, escalated to 50 mg/day in the second week. After the fourth week, the patient experienced a reduction in urticaria but reported fatigue, malaise, and low-grade fever, alongside marked, progressive, and dose-dependent neutrophilic leukocytosis. The leukocyte count surged from a baseline of 6,700/μL to a peak of 26,600/μL, with the presence of immature forms (band neutrophils). Dapsone was discontinued, and multiple studies (bacterial cultures, biochemical profile, bone marrow aspiration and biopsy) were performed to rule out infectious processes or a primary myeloid disorder (such as a myeloproliferative neoplasm). Results confirmed a hypercellular bone marrow with preserved maturation and no evidence of malignancy. Following the discontinuation of dapsone and a 10-day course of prednisone combined with antihistamines, leukocyte counts returned to normal within eight weeks. Strict hematologic monitoring and careful risk-benefit assessment are essential when dapsone is considered in settings with limited access to biologic therapies for CSU.

PMID 43037219
阅读全文 →
PubMedJournal of hazardous materials2026-11-11

Effect-concentration rankings between pharmaceuticals and their transformation products vary across biological test contexts.

Kumar Lokesh L, Purkait Mihir Kumar MK

Removing a pharmaceutical parent during treatment does not necessarily reduce biological effects because its transformation products may behave differently across tests. We analysed 226 primary exact endpoint records representing 70 parent-product relationships, 26 parent-study units, and 22 pharmaceutical parents. Effect concentrations were expressed in molar units and summarized successively by relationship, parent-study unit, and parent to limit the influence of repeated observations. Median log10 product-to-parent shifts were -0.085 (95% CI, -0.405-0.072) across relationships and -0.116 (-0.485-0.203) across parents, with no consistent direction within this evidence set. Including censored evidence classified 14 of 24 parents as necessarily negative, nine as necessarily positive, and one as indeterminate. Among 52 relationships examined in multiple biological contexts, 30 changed sign and 21 reversed beyond a twofold margin. Valsartan and loratadine contributed 18 of these 21; excluding both left 3 of 31. Context differences weakened after aggregation to parents. Only three pairs had co-measured occurrence concentrations, so that comparison remained illustrative. These findings support compound-specific ranking changes rather than a universal direction and show why treatment-safety claims must distinguish parent removal, product formation, biological response, and site-specific exposure.

PMID 43014173
阅读全文 →
PubMedNature cancer2026-11-04

Basophils inhibit early lung metastasis by suppressing regulatory T cells.

Torchia Bruno B, Fournier Nadine N, Yücel Simge S, Fournier Morgane M et al.

Basophils are rare cells best known for their role in allergy but their contribution to cancer remains poorly understood. Here, we found that basophils suppress early lung metastatic seeding in mice by enhancing antitumor CD8+ T cell immunity through inhibition of regulatory T (Treg) cells. Basophils restrain Treg cells through two complementary mechanisms: mast cell protease 8-mediated cleavage of interleukin-2 receptor α and histamine-mediated activation of the histamine H1 receptor (HRH1). HRH1 blockade with loratadine abolished Treg cell suppression and accelerated metastatic seeding in mice. In a prospective double-blind crossover trial of loratadine versus placebo enrolling 40 healthy volunteers ( IRCT20170608034390N14 ), circulating Treg cell frequency (primary outcome) increased following loratadine. Higher blood basophil counts predicted improved survival across human cancers and integrative multiomic analyses identified conserved quiescent (B0) and tumor-associated (B1) basophil states, with B0 predicting favorable outcomes. These findings identify basophils as regulators of early metastatic progression and highlight the basophil-Treg cell axis as a potential therapeutic target.

PMID 42977840
阅读全文 →
PubMedMolecular pharmaceutics2026-11-02

Structural Response of Amorphous Active Pharmaceutical Ingredients with Flexible Molecules to High Pressure.

Janowska Anna A, Garbarino Gaston G, Rodrigues Joao Elias F S JEFS, Gallego Parra Samuel S et al.

The objective of this study was to examine the intra- and intermolecular structure of two active pharmaceutical ingredients characterized by van der Waals flexible moleculesprobucol and loratadinein their liquid and glassy states under ambient and high-pressure conditions. We investigated how compression influences local packing motifs in these systems and whether the structural features observed in supercooled liquids under ambient and high-pressure conditions resemble those found in ordinary and pressure-densified glasses. Structural evolution was characterized using ambient- and high-pressure X-ray diffraction supported by molecular dynamics simulations. Total and partial structure factors, pair distribution functions, and local structural parameters were calculated from molecular dynamics models that were consistent with experimental diffraction data. The results show that compression primarily modifies local molecular packing and the distribution of various intermolecular contacts while inducing only minimal changes in the conformations of these flexible molecules. Regarding the intermolecular structure, compression affects the medium-range order, increases local structural heterogeneity, and enhances the population of short O-H···S and Cl···Cl contacts. These features are less pronounced in the corresponding liquid and glass states at ambient pressure, within the pressure and temperature ranges studied here, as well as in crystal structures. Upon decompression, these structural characteristics may either relax or exhibit partial similarity to those observed in supercooled pressurized liquids. While analogous phenomena have been discussed for glasses with highly interconnected networks (such as silica-based glasses), our results indicate that similar effects can also appear in molecular pharmaceutical systems. Our results provide molecular-level insight into pressure-induced structural organization in pharmaceutical liquids and motivate further studies on how such structural changes may relate to the properties of the resulting glassy states.

PMID 42969720
阅读全文 →
PubMedACS omega2026-10-25

Loratadine Decreases Methicillin-Resistant Staphylococcus aureus Virulence through Global Hemolysin Regulators vraSR and agr.

Dillon Chase C, Marshall Isabel I, Henkel Maggy M, Balogh Halie H et al.

Methicillin-resistantStaphylococcus aureus-(MRSA) is a bacterial pathogen that relies on expression of a wide range of virulence factors. Hemolysins are a diverse collection of cytolytic toxins that promote virulence by being excreted and lysing host blood cells. We previously reported on novel antivirulence compounds that modulate hemolysis in vitro, including a brominated carbazole (compound 8) and the active ingredient in Claritin (loratadine). We analyzed expression and activity of MRSA hemolysins in two hospital-acquired strains. Even with the same staphylococcal cassette chromosome mec (SCCmec) type, the strains displayed unique responses to loratadine where both repression and elevation of hemolysis occurred. These compounds are potentially binding and regulating the master regulatory protein, Stk1, which has known ties to hemolysis inS. aureus. We hypothesized that the modulation of hemolysis by these putative Stk1 inhibitors would extend to community-acquired strains of MRSA. Furthermore, we wanted to determine if Stk1 was the only hemolysis regulatory protein being engaged by these compounds. To test this, we examined compound 8 and loratadine effects on two different USA300 strains, in addition to transposon mutants for a range of hemolysis regulatory genes. We observed strain-specific regulation of hemolysis by Stk1. Loratadine continued to downregulate both alpha and beta hemolytic activity in USA300 JE2 in both Stk1-dependent and independent pathways. Additionally, we report that this antivirulence compound effectively disrupts hemolysis by modulating both agr and vraSR global regulators, contributing to widespread cytotoxin repression. Both alpha hemolysin (hla) and RNAIII/delta hemolysin (hld) mRNA reductions occurred in vitro and in a human cell line model of MRSA infection. Together, these results expand our knowledge of loratadine's mode of action as a virulence modulator.

PMID 42923371
阅读全文 →

注册免费账户还可查看另外 1427 篇文献

免费注册查看全部文献 →

了解更多loratadine